EFFECT OF THE ERGOT INHIBITOR (CLAVICEPS PURPUREA L.) ON THE TOBACCO MOSAIC VIRUS (TMV).
D000998:Antiviral Agents; D001203:Ascomycota; D002317:Cardiovascular Agents; D002967:Claviceps; D004874:Ergonovine; D004876:Ergot Alkaloids; D010120:Oxytocics; D010600:Pharmacology; D012313:RNA; D012367:RNA, Viral; D012106:Research; D014027:Tobacco Mosaic Virus
D000998:Antiviral Agents; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010120:Oxytocics; D012367:RNA, Viral; D012313:RNA; D004874:Ergonovine
ANTIVIRAL AGENTS; ASCOMYCETES; ERGOT ALKALOIDS; EXPERIMENTAL LAB STUDY; PHARMACOLOGY; RNA, VIRAL; TOBACCO MOSAIC VIRUS